Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins

Prostate

Volumn 33, Issue 2, 1997, Pages 105-111

  Meikle, A Wayne ^a   Stephenson, Robert A ^a   Lewis, Cathryn M ^a   Wiebke, Gail A ^a   Middleton, Richard G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Androgens; Genetic; Hyperplasia; Twins

Indexed keywords

ANDROSTENEDIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; BODY FAT; DIZYGOTIC TWINS; ESTRADIOL BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; GENETIC SUSCEPTIBILITY; HUMAN; LEAN BODY WEIGHT; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK ASSESSMENT; RISK FACTOR; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AGING; BODY MASS INDEX; BODY WEIGHT; DEHYDROEPIANDROSTERONE SULFATE; DIHYDROTESTOSTERONE; ELECTRIC IMPEDANCE; ENVIRONMENT; ESTRADIOL; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 0030763333     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19971001)33:2<105::AID-PROS4>3.0.CO;2-J     Document Type: Article

References (43)

1. Meikle AW, Stephenson RA, McWhorter WP, Skolnick MH, Middleton RG: Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer. Prostate 1995;26:253-259.
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL: Development of benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
3. Epstein RS, Lydick E, deLabry L, Vokonas P: Age related factors for prostatectomy for benign prostatic hyperplasia: The VA Normative Aging Study. Urology 1991;38:9-12.
4. Moore RA: Benign hypertrophy and carcinoma of the prostate. Occurrence and experimental production in animals. Surgery 1944;16:152-167.
5. Coffey D, Walsh P: Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990;17:461-475.
6. Longcope C, Goldfield SR, Brambilla DJ, McKinlay J: Androgens, estrogens, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1990;71:1442-6.
7. Gray A, Feldman HA, McKinlay JB, Longcope C: Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016-1025.
8. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC: Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate 1995;27:25-31.
9. Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB: The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994;79:1310-3106.
10. Terris MK, McNeal JE, Stamey TA: Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 1992;147:855-857.
11. Rahmouni A, Yang A, Tempany CM, Frenkel T, Epstein J, Walsh P, Leichner PK, Ricci C, Zerhouni E: Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr 1992;16:935-940.
12. Wolff JM, Boeckmann W, Mattelaer P, Handt S, Adam G, Jakse G: Determination of prostate gland volume by transrectal ultrasound: Correlation with radical prostatectomy specimens. Eur Urol 1995;28:10-12.
13. Myschetzky PS, Suburu RE, Kelly BS Jr, Wilson ML, Chen SC, Lee F: Determination of prostate gland volume by transrectal ultrasound: Correlation with radical prostatectomy specimens. Scand J Urol Nephrol [Suppl] 1991;137:107-111.
14. Meikle AW, Stringham JD, Woodward MG, Nelson JC: Hereditary and environmental influences on the variation of thyroid hormones in normal male twins. J Clin Endocrinol Metab 1988; 66:588-592.
15. Meikle AW, Bishop DT, Stringham JD, West DW: Quantitating genetic and nongenetic factors that determine plasma sex-steroid variation in normal male twins. Metabolism 1986;35: 1090-1095.
16. Meikle AW, Stringham JD, Bishop DT, West DW: Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men. J Clin Endocrinol Metab 1988;67: 104-109.
17. Bishop DT, Meikle AW, Slattery ML, Stringham JD, Ford MH, West DW: The effect of nutritional factors on sex hormone levels in male twins. Genet Epidemiol 1988;5:43-59.
18. Meikle AW, Bishop DT, Stringham JD, Ford MH, West DW: Relationship between body mass index, cigarette smoking and plasma sex-steroids in normal male twins. Genet Epidemiol 1989;6:399-412.
19. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK, Association TMCotAU: The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549-1557.
20. Meikle AW, Stanish WM, Taylor N, Edwards CQ, Bishop CT: Familial effects on plasma sex-steroid content in man: Testosterone, estradiol and sex hormone-binding-globulin. Metabolism 1982;31:6-9.
21. Meikle AW, Stringham JD, Bishop DT, West DW: Plasma sex-steroid content: Genetic and nongenetic familial factors in male twins. Clin Res 1985;34:93.
22. Ohe H, Watanabe H: Kinetic analysis of prostatic volume in treating prostatic cancer and its predictability for prognosis. Cancer 1988;62:2325-2329.
23. Ohnishi K, Watanabe H, Ohe H: Development of benign prostatic hypertrophy. Tohoku J Exp Med 1987;151:51-56.
24. Segal KR, Gutin B, Presta E, Wang J, Itallie T: Estimation of human body composition by electrical impedance methods: A comparative study. J Appl Physiol 1985;58:1565-1571.
25. Lukaski HC, Bolonchuk WW: Theory and validation of the bioelectrical impedance method to assess human body composition. International Symposium on In Vivo Body Composition Studies. J Appl Physiol 1986;60:1327-1332.
26. Lukaski HC, Johnson PE, Bolonchuk WW, Hall CB, Siders W: Assessment of fat free mass using bio-electrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810-817.
27. Smith CAB: On the estimation of intraclass correlation. Ann Hum Genet 1957;21:363-373.
28. Smith C: Concordance in twins: Methods and interpretation. Am J Hum Genet 1974;26:454-466.
29. Christian JC, Kang KW, Norton JA: Choice of an estimate of genetic variance from twin data. Am J Hum Genet 1974;26:154-161.
30. Vogel F, Mutulsky AG: "Human Genetics," New York: Springer-Verlag, 1979:173-188.
31. Smith TW, Turner CW, Ford MH, Hunt SC, Barlow GK, Stults BM, Williams RR: Blood pressure reactivity in adult male twins. Health Psychol 1987;6:209-220.
32. Smith SD: Identification of genetic influences. Clin Commun Disord 1992;2:73-85.
33. Hartl D: "Principles of Population Genetics," Sunderland, MA: Sinnuer, 1980.
34. Guess HA: Benign prostatic hyperplasia: Antecedents and natural history. Epidemiol Rev 1992;14:131-153.
35. Jakobsen H, Torp-Pedersen S, Juul N: Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. Scand J Urol Nephrol 1988;107:26-31.
36. Greene DR, Egawa S, Hellerstein DK, Scardino PT: Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia. Urology 1990;36:293-299.
37. Guess HA: The natural history of benign prostatic hyperplasia: Implications for patient care and clinical trial design. Eur Urol [Suppl] 1994;25:10-14.
38. Gabrilove JL, Levine AC, Kirschenbaum A, Droller M: Effect of long-acting gonadotropin-releasing hormone analog (leuprolide) therapy on prostatic size and symptoms in 15 men with benign prostatic hypertrophy. J Clin Endocrinol Metab 1989;69: 629-632.
39. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-Mcginley J, McConnell JD, Walsh PG, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Pappas F, Taylor A, Binkowitz B, Ng J: The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992;327:1185-1191.
40. Tempany CMC, Partin AW, Zerhouni SJ, Zinreich SJ, Walsh PC: The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate 1993;22:39-42.
41. Partin AW, Page WF, Lee BR, Sanda MG, Miller RN, Walsh PC: Concordance rates for benign prostatic disease among twins suggest hereditary influence. Urology 1994;44:646-650.
42. Sanda MG, Beary TH, Stutzman RE, Childs B, Walsh PC: Genetic susceptibility of benign prostatic hyperplasia. J Urol 1994; 152:115-119.
43. Meikle A, Stephenson R, Lewis C, Middleton R: Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinol Metab 1997;82:571-575.